A Randomized Trial of the Efficacy and Safety of Fenofibrate versus Pravastatin in HIV-Infected Subjects with Lipid Abnormalities: AIDS Clinical Trials Group Study 5087-Reference-Cited by-同舟云学术

A Randomized Trial of the Efficacy and Safety of Fenofibrate versus Pravastatin in HIV-Infected Subjects with Lipid Abnormalities: AIDS Clinical Trials Group Study 5087

Published:2005-09 Issue:9 Volume:21 Page:757-767
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Aberg Judith A.¹,Zackin Robert A.²,Brobst Susan W.³⁴,Evans Scott R.²,Alston Beverly L.⁵,Henry W. Keith⁶,Glesby Marshall J.⁷,Torriani Francesca J.⁸,Yang Yijun²⁹,Owens Susan I.¹⁰,Fichtenbaum Carl J.¹¹

Affiliation:

1. New York University, New York, New York 10016.

2. Harvard School of Public Health, Boston, Massachusetts 02115.

3. Social and Scientific Systems, Inc., Silver Spring, Maryland 20910.

4. Present address: National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.

5. National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.

6. University of Minnesota, Minneapolis, Minnesota 55455.

7. Weill Medical College of Cornell University, New York, New York 10021.

8. University of California, San Diego, La Jolla, California 92093.

9. Present address: Wyeth Laboratories, Madison, New Jersey.

10. Frontier Science and Technology Research Foundation, Chestnut Hill, Massachusetts 02467.

11. University of Cincinnati, Cincinnati, Ohio 45221.